A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19

A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19

ObjectiveTo objectively evaluate the efficacy of the Zilongjin tablets in non-small cell lung cancer (NSCLC) and to explore its potential mechanism of action against NSCLC and COVID-19 based on network pharmacology.MethodsThe database was searched for randomized controlled trials (RCTs) of the Zilon...

Full description

Bibliographic Details
Main Authors: Wuxia Yang, Yichao Zhang, Jing Gao, Pengcheng Hu, Yanjie Yang, Xiaoqing Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Medicine
Subjects:
Zilongjin tablets
non-small cell lung cancer (NSCLC)
COVID-19
traditional Chinese medicine
meta-analysis
network pharmacology
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1080121/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1080121/full

Similar Items